Paper52353
The effects of allopurinol and clofibrate on the elimination of coumarin anticoagulants in man.
Pond SM and 3 others. Aust N Z J Med, 1975. Cited by 24 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The effects of allopurinol and clofibrate on the elimination of coumarin anticoagulants in man. Papers, record 52353. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/52353
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The effects of allopurinol and clofibrate on the elimination of coumarin anticoagulants in man.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Allopurinol | Major topic |
| Clofibrate | Major topic |
| Dicumarol | Major topic |
| Warfarin | Major topic |
| Adult | |
| Biological Availability | |
| Blood Proteins | |
| Butyrates | |
| Half-Life | |
| Humans | |
| Male | |
| Protein Binding |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,539,118 | Patterns of deprescribing after an emergency department visit due to adverse drug events among concomitant users of antithrombotics and other medications. | medRxiv | 2026 | https://conductscience.org/library/papers/42539118 | PubMed |
| 23,616,817 | Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departments. | Dtsch Arztebl Int | 2013 | https://conductscience.org/library/papers/23616817 | PubMed |
| 6,347,619 | Drug interactions with warfarin. | Drugs | 1983 | https://conductscience.org/library/papers/6347619 | PubMed |
| 6,147,220 | Pharmacokinetic drug interactions with theophylline. | Clin Pharmacokinet | 1984 | https://conductscience.org/library/papers/6147220 | PubMed |
| 925,883 | Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin. | J Pharmacokinet Biopharm | 1977 | https://conductscience.org/library/papers/925883 | PubMed |
| 391,530 | Antiplatelet drugs: clinical pharmacology and therapeutic use. | Drugs | 1979 | https://conductscience.org/library/papers/391530 | PubMed |
| 338,281 | Interindividual differences in the response to oral anticoagulants. | Drugs | 1977 | https://conductscience.org/library/papers/338281 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/52353
GET https://conductscience.org/api/papers/v1/52353/authors